, Volume 164, Issue 2, pp 73–76 | Cite as

Isoelectric focusing and ELISA evaluation of a Blastomyces dermatitidis human isolate



Blastomyces dermatitidis is a dimorphic fungal organism and the causative agent of blastomycosis. This organism is endemic east of the Mississippi river as is the fungal organism Histoplasma capsulatum. This study was performed to determine if sensitive and specific antigens from the B. dermatitidis yeast phase lysate (human isolate 592) could be separated using isoelectric focusing (IEF) to eliminate antigens that are cross-reactive with H. capsulatum. Indirect enzyme linked immunosorbent assays were performed to test for reactivity and cross-reactivity and indicate that certain fractions (4–6) were highly reactive. Fraction 16 exhibited a high degree of cross-reactivity with H. capsulatum. This study indicates that IEF may be a useful method for the separation of B. dermatitidis proteins.


Blastomycosis Cross-reactivity ELISA Isoelectric focusing Protein 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



We would like to thank Dr. A.F. DiSalvo for providing the B. dermatitidis isolate 592. This research was funded in part by a grant from the Department of Biological Sciences, and from the Graduate Student Research and Scholarship Committee (S05-111), Idaho State University, Pocatello, Idaho.


  1. 1.
    Al-Doory Y. Introduction. In: Al-Doory Y, DiSalvo AF, editors. Blastomycosis. New York: Plenum Medical Book Company; 1992. p. 1–7.Google Scholar
  2. 2.
    Axtell RC, Scalarone GM. Serological differences in three Blastomyces dermatitidis strains. Mycoses 2002;45(11–12):437–42.PubMedGoogle Scholar
  3. 3.
    Abuodeh RO, Chester EM, Scalarone GM. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources. Mycoses 2004;47(3–4):143–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Chester EM, Axtell RC, Scalarone GM. Blastomyces dermatitidis lysate antigens: antibody detection in serial serum specimens from dogs with blastomycosis. Mycopathologia 2003;156(4):289–94.PubMedCrossRefGoogle Scholar
  5. 5.
    Roomiany PL, Axtell RC, Scalarone GM. Comparison of seven Blastomyces dermatitidis antigens for the detection of antibodies in humans with occupationally acquired blastomycosis. Mycoses 2002;45(8):282–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Sestero CM, Scalarone GM. Detection of IgG and IgM in sera from canines with blastomycosis using eight Blastomyces dermatitidis yeast phase lysate antigens. Mycopathologia 2006;162(1):33–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Shurley JF, Legendre AM, Scalarone GM. Blastomyces dermatitidis antigen detection in urine specimens from dogs with blastomycosis using a competitive binding inhibition ELISA. Mycopathologia 2005;160(2):137–42.PubMedCrossRefGoogle Scholar
  8. 8.
    Wheat J, French ML, Kamel S, Tewari RP. Evaluation of cross-reactions in Histoplasma capsulatum serologic tests. J Clin Microbiol 1986;23(3):493–9.PubMedGoogle Scholar
  9. 9.
    Wheat J, Wheat H, Connolly P, Kleiman M, Supparatpinyo K, Nelson K, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997;24(6):1169–71.PubMedGoogle Scholar
  10. 10.
    Klein BS, Vergeront JM, Weeks RJ, Kumar UN, Mathai G, Varkey B, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986;314(9):529–34.PubMedCrossRefGoogle Scholar
  11. 11.
    Bono JL, Legendre AM, Scalarone GM. Detection of antibodies and delayed hypersensitivity with Rotofor preparative IEF fractions of Blastomyces dermatitidis yeast phase lysate antigen. J Med Vet Mycol 1995;33(4):209–14.PubMedCrossRefGoogle Scholar
  12. 12.
    Fisher MA, Bono JL, Abuodeh RO, Legendre AM, Scalarone GM. Sensitivity and specificity of an isoelectric focusing fraction of Blastomyces dermatitidis yeast lysate antigen for the detection of canine blastomycosis. Mycoses 1995;38(5–6):177–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Johnson SM, Scalarone GM. Preparation and ELISA evaluation of Blastomyces dermatitidis yeast phase lysate antigens. Diagn Microbiol Infect Dis 1988;11(2):81–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Hall NK, Deighton F, Larsh HW. Use of an alkali-soluble water-soluble extract of Blastomyces dermatitidis yeast-phase cell walls and isoelectrically focused components in peripheral lymphocyte transformations. Infect Immun 1978;19(2):411–5.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  1. 1.Department of Biological SciencesIdaho State UniversityPocatelloUSA

Personalised recommendations